Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling

dc.contributor.authorJun, Jesse
dc.contributor.authorGoodnow, Christopher
dc.date.accessioned2015-12-13T23:08:16Z
dc.date.available2015-12-13T23:08:16Z
dc.date.issued2003
dc.date.updated2015-12-12T08:12:50Z
dc.description.abstractLymphocyte antigen receptors are responsible for inducing the opposite responses of immunity or tolerance. How the correct polarity of antigen receptor signaling is encoded has been an enduring enigma. Here we summarize recent advances defining key scaffolding molecules, CARMA1 (also known as CARD11) and the Cbl family of ubiquitin ligases, required for either immunogenic or tolerogenic signaling by antigen receptors. These scaffolding proteins may determine the polarity of response to antigen by promoting assembly around antigen receptors of competing multiprotein signal complexes: immunosomes versus tolerosomes. Each of the factors that influence immunogenicity or tolerogenicity-stage of lymphocyte differentiation, concurrent engagement of inhibitory or costimulatory receptors, extent of receptor crosslinking, and prior antigen experience-may be integrated in lymphocytes through their capacity to influence the probability of assembling immunosomes versus tolerosomes.
dc.identifier.issn1529-2908
dc.identifier.urihttp://hdl.handle.net/1885/86598
dc.publisherNature Publishing Group
dc.sourceNature Immunology
dc.subjectKeywords: B lymphocyte receptor; calcium ion; CD28 antigen; CD40 antigen; cytoskeleton protein; immunoglobulin enhancer binding protein; isoprotein; Janus kinase; lymphocyte antigen receptor; membrane protein; mitogen activated protein kinase; protein carma1; trans
dc.titleScaffolding of antigen receptors for immunogenic versus tolerogenic signaling
dc.typeJournal article
local.bibliographicCitation.issue11
local.bibliographicCitation.lastpage1064
local.bibliographicCitation.startpage1057
local.contributor.affiliationJun, Jesse, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationGoodnow, Christopher, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidJun, Jesse, u3274002
local.contributor.authoruidGoodnow, Christopher, u9710462
local.description.notesImported from ARIES
local.description.refereedYes
local.identifier.absfor110706 - Immunogenetics (incl. Genetic Immunology)
local.identifier.absfor110703 - Autoimmunity
local.identifier.ariespublicationMigratedxPub15512
local.identifier.citationvolume4
local.identifier.doi10.1038/ni1001
local.identifier.scopusID2-s2.0-0242708772
local.type.statusPublished Version

Downloads